Abstract
Since the 2009 pandemic, monoclonal antibodies (mAbs) for rapid influenza diagnostic tests (RIDT) have been developed for specific diagnostics of pandemic viral infection. Most of the mAbs were poorly characterized because of urgency during the pandemic. Further characterization of the mAbs for RIDTs would be beneficial for understanding the immunological properties of the pandemic virus and utilizing the mAbs for other research purposes. In this study, it was confirmed that two mAbs (I38 and D383) in an RIDT for H1N1pdm09 diagnostics were able to detect H1N1pdm09 virus through enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA). Also, the two mAbs exhibited reactivity to hemagglutinins (HAs) of both the H1N1pdm09 and 1918 H1N1 viruses; therefore, the RIDT using the mAbs could detect HAs of H1N1pdm09 and also HAs of 1918 H1N1-like strains. In an extension to our previous study, the epitopes (Sa antigenic site and the interface area of F’ and vestigial esterase subdomains on the HA1 domain of HA of H1N1pdm09) recognized by the mAbs were corroborated in depth by IFA with escape-mutants from the mAbs and mapping of the epitopes on the crystal structure of human H1N1 viral HAs. Collectively, these results imply that the mAbs for the RIDT may be suitable for use in studying the immunological properties of H1N1pdm09 viruses and that the Sa antigenic site and the interface area between F’ and vestigial esterase subdomains on influenza viral HA recognized by the mAbs are immunologically conserved regions between H1N1pdm09 and 1918 H1N1.
Article PDF
Similar content being viewed by others
References
Amano, Y. and Cheng, Q. 2005. Detection of influenza virus: traditional approaches and development of biosensors. Anal. Bioanal. Chem. 381, 156–164.
Brockwell-Staats, C., Webster, R.G., and Webby, R.J. 2009. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respir. Viruses 3, 207–213.
Carrat, F. and Flahault, A. 2007. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852–6862.
Choi, Y.J., Kim, H.J., Park, J.S., Oh, M.H., Nam, H.S., Kim, Y.B., Cho, B.K., Ji, M.J., and Oh, J.S. 2010. Evaluation of new rapid antigen test for detection of pandemic influenza A/H1N1 2009 virus. J. Clin. Microbiol. 48, 2260–2262.
Corti, D., Suguitan, A.L. Jr., Pinna, D., Silacci, C., Fernandez-Rodriguez, B.M., Vanzetta, F., Santos, C., Luke, C.J., Torres-Velez, F.J., and Temperton, N.J. 2010. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120, 1663.
Cutler, J., Schleihauf, E., Hatchette, T.F., Billard, B., Watson-Creed, G., Davidson, R., Li, Y., Bastien, N., and Sarwal, S. 2009. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181, 159–163.
Dawood, F.S., Iuliano, A.D., Reed, C., Meltzer, M.I., Shay, D.K., Cheng, P.Y., Bandaranayake, D., Breiman, R.F., Brooks, W.A., and Buchy, P. 2012. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687–695.
Dhiman, N., Espy, M.J., Irish, C., Wright, P., Smith, T.F., and Pritt, B.S. 2010. Mutability in the matrix gene of novel influenza A H1N1 virus detected using a FRET probe-based real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 48, 677–679.
Dormitzer, P.R., Galli, G., Castellino, F., Golding, H., Khurana, S., Del Giudice, G., and Rappuoli, R. 2011. Influenza vaccine immunology. Immunol. Rev. 239, 167–177.
Eisen, M.B., Sabesan, S., Skehel, J.J., and Wiley, D.C. 1997. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology 232, 19–31.
Gamblin, S., Haire, L., Russell, R., Stevens, D., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D., Daniels, R., and Elliot, A. 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838–1842.
García-Ojeda, P.A., Hardy, S., Kozlowski, S., Stein, K.E., and Feavers, I.M. 2004. Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria. Infect. Immun. 72, 3451–3460.
Germann, T.C., Kadau, K., Longini, I.M., and Macken, C.A. 2006. Mitigation strategies for pandemic influenza in the United States. Proc. Natl. Acad. Sci. USA 103, 5935–5940.
Grandea, A.G., Olsen, O.A., Cox, T.C., Renshaw, M., Hammond, P.W., Chan-Hui, P.Y., Mitcham, J.L., Cieplak, W., Stewart, S.M., and Grantham, M.L. 2010. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc. Natl. Acad. Sci. USA 107, 12658–12663.
Grund, S., Adams, O., Wählisch, S., and Schweiger, B. 2011. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J. Virol. Methods 171, 369–373.
Igarashi, M., Ito, K., Yoshida, R., Tomabechi, D., Kida, H., and Takada, A. 2010. Predicting the antigenic structure of the pandemic (h1n1) 2009 influenza virus hemagglutinin. PLoS One 5, e8553.
Kwon, D., Shin, K., Kwon, M., Oh, H.B., Kang, C., and Lee, J.Y. 2011. Development and evaluation of a rapid influenza diagnostic test for the pandemic (H1N1) 2009 influenza virus. J. Clin. Microbiol. 49, 437–438.
Landry, M.L. 2011. Diagnostic tests for influenza infection. Curr. Opin. Pediatr. 23, 91–97.
Manicassamy, B., Medina, R.A., Hai, R., Tsibane, T., Stertz, S., Nistal-Villán, E., Palese, P., Basler, C.F., and García-Sastre, A. 2010. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6, e1000745.
Medina, R.A., Manicassamy, B., Stertz, S., Seibert, C.W., Hai, R., Belshe, R.B., Frey, S.E., Basler, C.F., Palese, P., and García-Sastre, A. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat. Commun. 1, 28.
Miyoshi-Akiyama, T., Narahara, K., Mori, S., Kitajima, H., Kase, T., Morikawa, S., and Kirikae, T. 2010. Development of an immunochromatographic assay specifically detecting pandemic H1N1 (2009) influenza virus. J. Clin. Microbiol. 48, 703–708.
Mizuike, R., Sasaki, T., Baba, K., Iwamoto, H., Shibai, Y., Kosaka, M., Kubota-Koketsu, R., Yang, C.S., Du, A., and Sakudo, A. 2011. Development of two types of rapid diagnostic test kits to detect the hemagglutinin or nucleoprotein of the swine-origin pandemic influenza A virus H1N1. Clin. Vaccine Immunol. 18, 494–499.
Morris, G.A. 2009. Pandemic Influenza Planning. ASSE Professional Development Conference and Exhibition. American Society of Safety Engineers.
O’Donnell, C.D., Vogel, L., Wright, A., Das, S.R., Wrammert, J., Li, G.M., McCausland, M., Zheng, N.Y., Yewdell, J.W., and Ahmed, R. 2012. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. MBio 3, E00120–00112.
Okuno, Y., Isegawa, Y., Sasao, F., and Ueda, S. 1993. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552–2558.
Patel, M., Dennis, A., Flutter, C., and Khan, Z. 2010. Pandemic (H1N1) 2009 influenza. Br. J. Anaesth. 104, 128–142.
Peacey, M., Hall, R., Bocacao, J., and Huang, Q. 2009. Diagnostic assay recommended by the World Health Organization for swine origin influenza A (H1N1) virus cross-reacts with H5N1 influenza virus. J. Clin. Microbiol. 47, 3789–3790.
Pica, N., Hai, R., Krammer, F., Wang, T.T., Maamary, J., Eggink, D., Tan, G.S., Krause, J.C., Moran, T., and Stein, C.R. 2012. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. USA 109, 2573–2578.
Rich, R.L. and Myszka, D.G. 2004. Why you should be using more SPR biosensor technology. Drug Discov. Today: Technol. 1, 301–308.
Rudneva, I., Ignatieva, A., Timofeeva, T., Shilov, A., Kushch, A., Masalova, O., Klimova, R., Bovin, N., Mochalova, L., and Kaverin, N. 2012. Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res. 166, 61–67.
Samuel, D., Warrener, L., and Hoschler, K. 2011. Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis. J. Med. Virol. 83, 559–567.
Skehel, J.J. and Wiley, D.C. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann. Rev. Biochem. 69, 531–569.
Sriwilaijaroen, N. and Suzuki, Y. 2012. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 88, 226.
Stevens, J., Corper, A.L., Basler, C.F., Taubenberger, J.K., Palese, P., and Wilson, I.A. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303, 1866–1870.
Taubenberger, J.K. and Morens, D.M. 2006. 1918 Influenza: the mother of all pandemics. Rev. Biomed. 17, 69–79.
Yi, H., Kim, Y.H., Kim, J.S., Lee, N.J., Shin, K., Choi, J.H., Kwon, D., Lee, J.Y., and Kang, C. 2013. Impact of influenza virus escapemutations on influenza detection by the rapid influenza diagnostic test. J. Med. Virol. 85, 709–715.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yi, H., Lee, MS., Lee, JY. et al. Immunological characterization of monoclonal antibodies used in rapid influenza diagnostic test for detection of the 2009 pandemic influenza A(H1N1)pdm09 infection. J Microbiol. 53, 166–175 (2015). https://doi.org/10.1007/s12275-015-4642-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-4642-2